Semi-Annual Consolidated Statement Of Income

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7356776

Concept 2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
Semi-annual consolidated statement of income
Statement of income
Net sales
5,096,000,000 JPY
43,603,000,000 JPY
48,866,000,000 JPY
48,824,000,000 JPY
166,000,000 JPY
-41,000,000 JPY
5,187,000,000 JPY
41,916,000,000 JPY
47,300,000,000 JPY
-41,000,000 JPY
47,259,000,000 JPY
196,000,000 JPY
Cost of sales
25,193,000,000 JPY
24,893,000,000 JPY
Gross profit (loss)
23,631,000,000 JPY
22,366,000,000 JPY
Ordinary profit (loss)
5,631,000,000 JPY
5,246,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
18,104,000,000 JPY
17,324,000,000 JPY
Extraordinary income
2,889,000,000 JPY
121,000,000 JPY
Profit (loss) before income taxes
8,520,000,000 JPY
5,367,000,000 JPY
Operating profit (loss)
186,000,000 JPY
6,346,000,000 JPY
6,429,000,000 JPY
5,526,000,000 JPY
-103,000,000 JPY
-903,000,000 JPY
417,000,000 JPY
5,418,000,000 JPY
5,809,000,000 JPY
-767,000,000 JPY
5,041,000,000 JPY
-26,000,000 JPY
Non-operating income
Interest income
3,000,000 JPY
0 JPY
Dividend income
321,000,000 JPY
331,000,000 JPY
Non-operating income
378,000,000 JPY
402,000,000 JPY
Income taxes - current
2,151,000,000 JPY
1,036,000,000 JPY
Non-operating expenses
Interest expenses
31,000,000 JPY
38,000,000 JPY
Non-operating expenses
273,000,000 JPY
197,000,000 JPY
Income taxes - deferred
-88,000,000 JPY
148,000,000 JPY
Income taxes
2,062,000,000 JPY
1,184,000,000 JPY
Profit (loss)
6,458,000,000 JPY
4,183,000,000 JPY
Extraordinary income
Profit (loss) attributable to owners of parent
6,458,000,000 JPY
4,183,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-131,000,000 JPY
858,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-23,000,000 JPY
20,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
285,000,000 JPY
477,000,000 JPY
Other comprehensive income
130,000,000 JPY
1,355,000,000 JPY
Comprehensive income
6,588,000,000 JPY
5,538,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
6,588,000,000 JPY
5,538,000,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.